Background and Purpose-Several cardiovascular risk factors are associated with cognitive disorders in older persons.
C ardiovascular risk factors such as hypertension or diabetes are associated with cognitive impairment, 1,2 brain lesions, and atrophy, 3 as well as dementia. 4, 5 Although there is an increasing body of literature showing associations of cardiovascular risk factors to brain function and structure, there are fewer studies of the burden of atherosclerosis diffuse chronic arterial disease to cognition and whether these associations are mediated by pathological changes in brain structure. 6, 7 Atherosclerotic burden can be indirectly estimated by coronary artery calcium (CAC), 8 carotid intima-media thickness, and ankle-brachial index. Some studies have shown an association between carotid intima-media thickness or anklebrachial index with cognitive decline 9 and, separately, dementia; 10 however, CAC is a more sensitive 11, 12 and more reliable 13, 14 measure of atherosclerosis that captures the cumulative exposure to the individual.
The Age, Gene, Environment Susceptibility (AGES)-Reykjavik Study, a large population-based study with a reliable measure of CAC, a comprehensive cognitive assessment, and a brain MRI with a fully automated procedure for estimating the brain volumes, provides the opportunity to study the relation of CAC to brain function and structure. We hypothesize that an increasing load of CAC is strongly related to diminished cognitive performance and to dementia, as well as to lower brain volumes and greater burden of brain lesions. Furthermore, we hypothesize that the brain volumes and lesions mediate the relation of CAC with cognitive performance and dementia.
Materials and Methods
The AGES-Reykjavik was initiated in 2002 to examine environmental factors, genetic susceptibility, and gene/environment interaction in relation to disease and disability in the elderly. 15 Subjects (nϭ5764; age, 66 -98 years) recruited for the AGES-Reykjavik cohort came from the population-based Reykjavik Study cohort composed of men and women born 1907 to 1935 and living in Reykjavik at the time the study was initiated in 1967 by the Icelandic Heart Association. 16 As described previously, all eligible AGES-Reykjavik subjects participated in a comprehensive clinical evaluation, including cognitive testing, brain MRI, and a CT cardiac scan. 15 All participants signed an informed consent. The study was approved (VSN00-063) by the National Bioethics Committee in Iceland and the Institutional Review Board of the Intramural Research Program of the National Institute on Aging.
Coronary Artery Calcifications
The heart was imaged with Siemens Somatom Sensation 4 multidetector CT (Siemens Medical Solutions) with prospective electrocardiographic triggering. 15 CT scans were analyzed with a calcium scoring software, previously described as a part of the Multi-Ethnic Study of Atherosclerosis study. 17 CAC, quantified according to the Agatston method, 18 was the sum of all 4 coronary artery scores. Based on the reanalysis of 200 scans, the intrareader agreement was rϭ0.99 and the interobserver Spearman correlation of measure made by the 5 readers compared to an expert reader from the Multi-Ethnic Study of Atherosclerosis study was rϭ0.94.
Assessment of Cognition and Dementia
A battery of 6 different cognitive tests was administered to all participants. From these tests, 3 cognitive domain composite scores were calculated: (1) the memory composite score included the immediate and delayed recall of a modified version of the California Verbal Learning Test 19 ; (2) the speed of processing composite included the Figure Comparison Test, 20 the Digit Symbol Substitution Test, 21 and the Stroop Test part 1 and 2 22 ; and (3) the executive function composite included a short version of the Cambridge Neuropsychological Test Automated Battery Spatial Working Memory test, 23 the Digits Backward test, 21 and the Stroop test part 3. 22 Gender-specific composite measures were computed by converting raw scores on each test to standardized Z-scores separately by gender and averaging the Z-scores across the tests in each composite. 24 Inter-rater reliability for all tests was excellent (Spearman correlations range, 0.96 -0.99).
Dementia case ascertainment was a 3-step process described previously. 15 Briefly, all subjects were screened on cognitive function with the Mini-Mental State Examination 25 and Digit Symbol Substitution Test. 21 Those with positive screen results were administered a diagnostic battery of neuropsychological tests and, among them, those with positive screen results were examined by a neurologist and a proxy interview was administered. A consensus diagnosis, according to international guideline, was made by a panel that included a geriatrician, neurologist, neuropsychologist, and neuroradiologist.
Brain MRI Measures
All participants without contraindications were eligible for a brain MRI performed on a study-dedicated 1.5-T Signa Twinspeed system (General Electric Medical Systems). The image protocol, described previously, 25 included an axial T1-weighted 3-dimensional, T2*weighted gradient echo-type echo planar (T2*), a proton density/T2weighted fast-spin echo (T2), and a fluid-attenuated inversion recovery sequences.
The intracranial volume and the brain parenchyma compartments were segmented automatically with an AGES-Reykjavik Studymodified algorithm based on the Montreal Neurological Institute pipeline. 26 The volumes of gray matter, white matter, white matter lesion, and cerebrospinal fluid were estimated for each subject and divided by total intracranial volume, yielding a percent tissue volume. Total brain tissue volume was defined as the sum of gray matter volume, white matter volume, and white matter lesion volume. Cerebral infarcts (CI) were identified by trained radiographers as defects in the brain parenchyma with associated hyperintensity on T2 and fluid-attenuated inversion recovery images with a maximal diameter of at least 4 mm. For infarcts in the cerebellum and brain stem or infarcts with cortical involvement, no size criterion was required. Cerebral microbleeds (CMB) were defined as focal areas of signal void within the brain parenchyma that met the following criteria: visible on T2* images and smaller or invisible on T2 images, not abutting a parenchymal defect, and not showing any other structure in the signal-void area. 25 The average inter-rater reliability (weighted kappa) was 0.7 for both CI and CMB (presence/ absence) and intrarater reliability scores were 0.9 and 1.0, respectively, in 5% of all scans reread without knowledge of the previous reading.
Potential Confounders
Analyses were adjusted for demographic, health, and vascular risk factors associated with both CAC and cognitive function or dementia. [1] [2] [3] [4] [5] Presence of depressive symptoms was defined as a score of Ն6 on the Geriatric Depression Scale. 27 Education level (college or university vs lower education) and smoking history (never, ever) were assessed by questionnaire. Diabetes was defined as a history of diabetes, use of glucose-modifying medication, or a fasting blood glucose of Ͼ7 mmol/L. Hypertension was defined as measured systolic blood pressure Ն140 mm Hg or diastolic blood pressure Ն90 mm Hg, or self-reported doctor's diagnosis of hypertension, or using antihypertensive medications. Prevalent coronary heart disease was defined as self-reported history of coronary artery disease or coronary artery bypass surgery or angioplasty or angina pectoris on the Rose Angina Questionnaire, 28 or evidence on ECG of possible or probable myocardial infarction. We also adjusted the analyses for midlife systolic blood pressure and total cholesterol measured at the Reykjavik Study examination that occurred 25 years (SDϭ4.2) earlier, because these 2 variables were strongly associated with CAC and cognition.
Analytic Sample
Of the 5764 examined subjects, 453 did not have a CAC measure because of technical or medical reasons or refusal, leaving 5311 subjects with a measure of CAC. The 3 cognitive domains could be computed for 5215, of whom 4490 underwent brain MRI from which the brain volumes could be assessed. Complete data for this analysis therefore were available for 4250 subjects, including 165 with dementia diagnosed. Compared to the 4250 subjects with complete data, subjects with incomplete data (nϭ1514) were significantly older (76.3 [SD, 5.4] vs 79.5 [SD, 6.7]), had a higher rate of depressive symptoms, and were more likely to have diabetes and a history of smoking. At midlife they had higher systolic and diastolic blood pressures. The coronary artery calcium score, CI, and CMB, did not differ between the 2 groups after adjusting for age and gender.
Statistical Analyses
Because CAC load differed significantly between men and women, quartiles of distribution of CAC were calculated separately by gender and then pooled (thresholds for men: 60, 584, and 1498; thresholds for women: 12, 136, and 521). This ensures women are ranked and compared to other women and, similarly, men are compared to other men. White matter lesion volume was highly skewed so the measure was log-transformed; for clarity, we report the means of white matter lesion volume as antilogs.
General characteristics and cardiovascular risk factors of the sample were examined among subjects with and without dementia for each cognitive domain and across the quartiles of CAC. Logistic regression was used to evaluate the association with dichotomized variables and analysis of covariance was used to evaluate the association with continuous variables.
Analysis of covariance was used to calculate the adjusted means (and 95% confidence intervals) of the 3 cognitive domains for each quartile of CAC, and logistic regression was used to calculate the OR (95% confidence intervals) associated with each quartile of CAC. The overall difference among the quartiles and the linear trend across quartiles was tested. The first quartile was also compared to the 3 others. All primary analyses were adjusted for age and gender (by virtue of using gender-specific quartile cut points); we added education and presence of depressive symptoms (model 1) and then further adjusted the model for vascular risk factors (model 2).
The association of the different brain abnormalities to CAC was studied with logistic regression for CI and CMB and analysis of covariance for brain volumes, adjusted for age, education, and cardiovascular risk factors. To examine whether brain changes mediate the association of CAC to cognition, we entered into model 2 the structural findings in the brain.
Finally, to better understand the relation between cognition and CAC, we adjusted the models for age and for each brain characteristic (CI, CMB, and volumes) taken separately without any other adjustment. All analyses were performed using the statistical software package SAS Version 9.1 (SAS Institute).
Results
The median Agatston score of CAC was 278 among the 4250 subjects; median score was higher among men than women (584 vs 136). Increasing CAC quartile was associated with older age, presence of depressive symptoms, higher midlife systolic and diastolic blood pressures, and more hypertension treatment (Table 1 ). Older subjects in the higher quartiles of CAC were more likely to have hypertension and diabetes and were more likely to be smokers or former smokers.
Lower scores on each cognitive domain were strongly associated with older age, lower educational level, presence of depressive symptoms, and more cardiovascular risk factors and disease. Low scores were also associated with CI, CMB, lower brain volumes, and higher white matter lesion volume.
Compared to nondemented individuals, those with dementia were more often male, had lower body mass index, reported more depressive symptoms, and had a lower educational level.
In age-adjusted analyses, lower scores on each cognition domain were strongly related to higher CAC ( Table 2) . Adjustment for age, education, and presence of depressive symptoms (model 1) reduced the group differences in speed of processing and executive function, but the linear trend of decreasing cognitive score and increasing CAC remained significant (Pϭ0.001 and 0.01, respectively). The relation between memory and CAC, however, was attenuated and no longer significant. Additional adjustment for cardiovascular risk factors (model 2) did not substantially modify these results.
The percentage of dementia, adjusted for age, significantly increased with quartiles of CAC (quartile 1, 10.3%; quartile 2, 21.8%; quartile 3, 29.1%; quartile 4, 38.8%). Similar to the results with cognitive function, the association of CAC and dementia was markedly reduced in model 1, but the linear trend for dementia and higher CAC remained significant. The relation was only slightly attenuated by further adjustment for vascular risk factors in model 2.
With increasing CAC quartile, gray matter volume, white matter volume, and total brain tissue volume decreased, and white matter lesion volume increased, as did the likelihood of CMB and CI (Table 3) . Linear trends for a dose-response relation of CAC to brain volumes, CMB, and CI were all significant. The relation between the brain changes and CAC remained strongly significant after adjustment for age, education level, and vascular risk factors. When the brain volumes and brain lesions were entered into the models, the relation of CAC to speed of processing and executive function was strongly attenuated and the overall difference between the CAC quartiles and the linear relation was no longer significant (Tables 3 and 4 ). Similarly, the relation of CAC and dementia was dramatically weakened when MRI brain volumes and brain lesions were added into the model (Tables 3 and 4 ).
Finally, in models only adjusted for age and gender, taking into the model each brain characteristic separately (ie, CI, CMB, and MRI brain volumes), we found that the magnitude and significance of the associations of CAC to cognitive domain and dementia were dramatically reduced by the addition of brain volumes and marginally reduced by the addition of CI or CMB (Supplemental Table I , available online at http://stroke.ahajournals.org).
Discussion
We found that increasing calcification of the coronary arteries, a robust cumulative measure of atherosclerosis, was associated with decreased cognitive speed of processing, executive function, and increase risk of dementia in a large, well-described cohort of men and women with an average age of 76 years. We also found that these relations were mediated by brain volumes and lesions.
The strength of this study lies in the large number of participants and the quality and reproducibility of assessment of the different outcomes. Cognitive function was assessed with a robust battery of tests that allowed us to develop more stable measures of 3 different cognitive domains: memory, speed of processing, and executive function. 24 This study has some limitations that should be taken into account when interpreting the results. Subjects not included in this analysis were older, more often had diabetes, and had higher levels of systolic blood pressure at midlife. Furthermore, they had significantly lower cognitive performance and lower brain volumes. Therefore, the proportion of people with low cognitive performance, as well as lower brain volumes and higher CAC, may be underrepresented in this analysis. However, there is no reason to suggest a differential association of CAC to cognitive function between subjects included or not from the analysis.
The magnitude of the association of CAC with speed of processing and executive function did not diminish after adjustment for cardiovascular risk factors. This likely reflects the fact that CAC is a measure of lifetime exposure to these risk factors, which lead to atherosclerosis.
Before adjusting for brain structure, CAC was significantly associated with speed of processing and executive function, but not with memory. In addition, increasing CAC was associated with an increased risk for dementia. These results are consistent with other published studies showing memory is not significantly associated with atherosclerosis burden. 7, 29 Speed of processing and executive function involve the subcortical network, which is particularly susceptible to ischemic damage. 30 Compared to patients with Alzheimer disease, patients with cerebrovascular cognitive impairment have characteristically more impaired test results on speed and executive functions than on memory. 31 CAC was associated with CI, CMB, and brain tissue volumes in a linear dose-response relation. The increased risk for CI as CAC increases has been reported in other large, population-based cohorts. 32, 33 Other atherosclerosis markers such as carotid intima-media thickness or ankle-brachial index have also been reported to be associated with brain lesion and atrophy, 34, 35 but these studies have little or no measures of brain function.
Finally, the relations of increasing CAC with dementia and with decreasing scores on tests of speed of processing and executive function were most strongly mediated by brain volumes and less so by CI or CMB. This analysis suggests atherosclerosis may lead to more diffuse, as opposed to focal, damage in the brain. The dementia results are consistent with the findings from the Cardiovascular Health Study of 727 participants, suggesting that the association of dementia with CAC was not independent of brain atrophy and white matter lesion volume. 7 The association of CAC to cognitive function was not assessed in that study.
Conclusion
Overall, this study shows that coronary atherosclerosis, measured with the CAC, is associated with pathological changes in the brain that have functional consequences ranging in severity from mild to severe cognitive function. Additional research is needed to understand how atherosclerosis interacts with other factors, such as hemodynamic changes, to damage the brain. On a practical basis, these findings highlight the chances that individuals who present with high CAC may also have concomitant cerebral damage that should be investigated.
